Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with direct oral anticoagulants

HIGHLIGHTS

• who: Mariana Corrochano and colleagues from the d`Investigacions Biomu00e8diques Sant Pau (IIB-Sant Pau), Barcelona, SpainEditor: Sreeram VRamagopalan, University of have published the research: Impact of increased kidney function on clinical and biological outcomes in real-world patients treated with Direct Oral Anticoagulants, in the Journal: PLOS ONE of November/21,/2022
• what: The aim of this study was to compare, in real-life practice, characteristics, biological parameters (anti-Xa activity), and thrombotic/haemorrhagic complication rates in DOAC-treated patients with GFR=90 mL/min vs GFR and amp;lt;90mL/min. Note that . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.